Literature DB >> 22110085

Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine.

Angela Rago, Lorenzo Ridola, Miriam Lichtner, Sergio Mecarocci, Raffaella Marocco, Natalia Cenfra, Valeria Belvisi, Claudio M Mastroianni, Giuseppe Cimino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22110085     DOI： 10.1093/jac/dkr486

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

Review 1.  Hepatitis B virus management to prevent reactivation after chemotherapy: a review.

Authors:  Jessica P Hwang; John M Vierling; Andrew D Zelenetz; Susan C Lackey; Rohit Loomba
Journal:  Support Care Cancer       Date:  2012-08-30       Impact factor: 3.603

2.  Chemotherapy-related reactivation of hepatitis B infection: updates in 2013.

Authors:  Hwi Young Kim; Won Kim
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

3.  Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.

Authors:  Jessica P Hwang; Michael J Fisch; Anna S-F Lok; Hong Zhang; John M Vierling; Maria E Suarez-Almazor
Journal:  BMC Cancer       Date:  2013-11-09       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.